
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $82M | $68M | -- | -- | |
Revenue Growth (YoY) | -- | -- | -17.07% | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $179.4M | $697M | $677M | $716M | $676M | |
Selling, General & Admin | $38.7M | $116M | $129M | $119M | $110M | |
Other Inc / (Exp) | -$45K | -$29M | -$985M | $39M | $38M | |
Operating Expenses | $218.1M | $813M | $806M | $835M | $786M | |
Operating Income | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$214.4M | -$760M | -$1.7B | -$796M | -$748M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2K | -$5M | -- | -- | -- | |
Net Income to Company | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
Basic EPS (Cont. Ops) | -$0.19 | -$1.22 | -$1.51 | -$0.60 | -$0.46 | |
Diluted EPS (Cont. Ops) | -$0.19 | -$1.22 | -$1.51 | -$0.60 | -$0.46 | |
Weighted Average Basic Share | $1.1B | $621M | $1.1B | $1.3B | $1.6B | |
Weighted Average Diluted Share | $1.1B | $621M | $1.1B | $1.3B | $1.6B | |
EBITDA | -$215M | -$715M | -$716M | -$814M | -$765M | |
EBIT | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
Revenue (Reported) | -- | $82M | $68M | -- | -- | |
Operating Income (Reported) | -$218.1M | -$731M | -$738M | -$835M | -$786M | |
Operating Income (Adjusted) | -$218.1M | -$731M | -$738M | -$835M | -$786M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $42M | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $159.1M | $154M | $177M | $166M | $182M | |
Selling, General & Admin | $32.7M | $31M | $31M | $27M | $29M | |
Other Inc / (Exp) | -$44K | $66M | $12M | $28M | $3M | |
Operating Expenses | $191.8M | $185M | $208M | $193M | $211M | |
Operating Income | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$191.3M | -$77M | -$196M | -$165M | -$208M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.6M | -- | -- | -- | -- | |
Net Income to Company | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Basic EPS (Cont. Ops) | -$0.17 | -$0.07 | -$0.17 | -$0.11 | -$0.12 | |
Diluted EPS (Cont. Ops) | -$0.17 | -$0.07 | -$0.17 | -$0.11 | -$0.12 | |
Weighted Average Basic Share | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | |
Weighted Average Diluted Share | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | |
EBITDA | -$185.8M | -$137M | -$203M | -$188M | -$205M | |
EBIT | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Revenue (Reported) | -- | $42M | -- | -- | -- | |
Operating Income (Reported) | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Operating Income (Adjusted) | -$191.8M | -$143M | -$208M | -$193M | -$211M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $691.9M | $700M | $705M | $692M | |
Selling, General & Admin | -- | $114.3M | $129M | $115M | $112M | |
Other Inc / (Exp) | -$44K | $36.5M | -$1B | $55M | $13M | |
Operating Expenses | -- | $806.2M | $829M | $820M | $804M | |
Operating Income | -- | -$682.2M | -$803M | -$820M | -$804M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$645.7M | -$1.8B | -$765M | -$791M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$2.4M | -- | -- | -- | |
Net Income to Company | -- | -$643.4M | -$1.8B | -$765M | -$791M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$643.4M | -$1.8B | -$765M | -$791M | |
Basic EPS (Cont. Ops) | -- | -$0.57 | -$1.61 | -$0.54 | -$0.48 | |
Diluted EPS (Cont. Ops) | -- | -$0.57 | -$1.61 | -$0.54 | -$0.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$666.2M | -$782M | -$799M | -$782M | |
EBIT | -- | -$682.2M | -$803M | -$820M | -$804M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$682.2M | -$803M | -$820M | -$804M | |
Operating Income (Adjusted) | -- | -$682.2M | -$803M | -$820M | -$804M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $42M | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $159.1M | $154M | $177M | $166M | $182M | |
Selling, General & Admin | $32.7M | $31M | $31M | $27M | $29M | |
Other Inc / (Exp) | -$44K | $66M | $12M | $28M | $3M | |
Operating Expenses | $191.8M | $185M | $208M | $193M | $211M | |
Operating Income | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$191.3M | -$77M | -$196M | -$165M | -$208M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.6M | -- | -- | -- | -- | |
Net Income to Company | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Basic EPS (Cont. Ops) | -$0.17 | -$0.07 | -$0.17 | -$0.11 | -$0.12 | |
Diluted EPS (Cont. Ops) | -$0.17 | -$0.07 | -$0.17 | -$0.11 | -$0.12 | |
Weighted Average Basic Share | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | |
Weighted Average Diluted Share | $1.1B | $1.1B | $1.2B | $1.5B | $1.7B | |
EBITDA | -$185.8M | -$137M | -$203M | -$188M | -$205M | |
EBIT | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Revenue (Reported) | -- | $42M | -- | -- | -- | |
Operating Income (Reported) | -$191.8M | -$143M | -$208M | -$193M | -$211M | |
Operating Income (Adjusted) | -$191.8M | -$143M | -$208M | -$193M | -$211M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $387.3M | $1.6B | $262M | $501M | $211M | |
Short Term Investments | -- | -- | $839M | $699M | $1B | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $18.9M | -- | -- | -- | -- | |
Other Current Assets | -- | $67M | $17M | $17M | $31M | |
Total Current Assets | $406.4M | $1.7B | $1.1B | $1.2B | $1.3B | |
Property Plant And Equipment | $101.8M | $245M | $229M | $216M | $224M | |
Long-Term Investments | -- | -- | -- | $148M | -- | |
Goodwill | $30M | $1.1B | -- | -- | -- | |
Other Intangibles | $52.7M | $617M | $618M | $617M | -- | |
Other Long-Term Assets | $12.3M | $37M | $36M | $37M | $43M | |
Total Assets | $618.9M | $3.7B | $2B | $2.2B | $2.1B | |
Accounts Payable | $6.5M | -- | -- | -- | -- | |
Accrued Expenses | $3.4M | $28M | $70M | $31M | $28M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $6.7M | $12M | $13M | $15M | $16M | |
Other Current Liabilities | $1.4M | -- | -- | -- | -- | |
Total Current Liabilities | $32M | $91M | $83M | $111M | $105M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $895.5M | $348M | $217M | $250M | $263M | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -$2M | $1M | $1M | |
Common Equity | -$276.6M | $3.3B | $1.8B | $2B | $1.9B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$276.6M | $3.3B | $1.8B | $2B | $1.9B | |
Total Liabilities and Equity | $618.9M | $3.7B | $2B | $2.2B | $2.1B | |
Cash and Short Terms | $387.3M | $1.6B | $1.1B | $1.2B | $1.2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $504.3M | $175M | $454M | $170M | |
Short Term Investments | -- | $964.4M | $791M | $662M | $989M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | $22.9M | -- | -- | -- | |
Other Current Assets | -- | -- | $14M | $26M | $34M | |
Total Current Assets | -- | $1.5B | $980M | $1.1B | $1.2B | |
Property Plant And Equipment | -- | $246.6M | $227M | $213M | $219M | |
Long-Term Investments | -- | -- | -- | $81M | -- | |
Goodwill | -- | $1.1B | -- | -- | -- | |
Other Intangibles | -- | $618.1M | -- | -- | -- | |
Other Long-Term Assets | -- | $36.6M | $42M | $36M | $42M | |
Total Assets | -- | $3.5B | $1.9B | $2.1B | $2.1B | |
Accounts Payable | -- | $4.3M | -- | -- | -- | |
Accrued Expenses | -- | $15.7M | $23M | $27M | $33M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $12.1M | $15M | $15M | $16M | |
Other Current Liabilities | -- | $2.6M | -- | -- | -- | |
Total Current Liabilities | -- | $49M | $103M | $110M | $125M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $239.5M | $238M | $231M | $286M | |
Common Stock | -- | $11K | -- | -- | -- | |
Other Common Equity Adj | -- | -$1.7M | -$1M | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | $397.9M | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | $3.3B | $1.6B | $1.9B | $1.8B | |
Total Liabilities and Equity | -- | $3.5B | $1.9B | $2.1B | $2.1B | |
Cash and Short Terms | -- | $1.5B | $966M | $1.1B | $1.2B | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$214.4M | -$755M | -$1.7B | -$796M | -$748M | |
Depreciation & Amoritzation | $3.1M | $16M | $22M | $21M | $21M | |
Stock-Based Compensation | $16.9M | $220M | $156M | $160M | $144M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$191.9M | -$564M | -$508M | -$598M | -$611M | |
Capital Expenditures | $6.7M | $48M | $15M | -- | -- | |
Cash Acquisitions | -- | $294M | -- | -- | -- | |
Cash From Investing | $343.3M | $250M | -$852M | $8M | -$172M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -$532K | -- | -- | -- | -- | |
Other Financing Activities | -- | $1.1B | -$2M | -$9M | -$5M | |
Cash From Financing | $1.4M | $1.5B | $11M | $831M | $492M | |
Beginning Cash (CF) | $247M | $400M | $1.6B | $277M | $518M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $152.9M | $1.2B | -$1.3B | $241M | -$291M | |
Ending Cash (CF) | $399.8M | $1.6B | $277M | $518M | $227M | |
Levered Free Cash Flow | -$198.6M | -$612M | -$523M | -$613M | -$645M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Depreciation & Amoritzation | $6M | $6M | $5M | $5M | $6M | |
Stock-Based Compensation | $36.9M | $29M | $39M | $36M | $34M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$151M | -$136M | -$136M | -$150M | -$142M | |
Capital Expenditures | -- | $5M | -- | -- | -- | |
Cash Acquisitions | $294.4M | -- | -- | -- | -- | |
Cash From Investing | $291.1M | -$971M | $54M | $101M | $19M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1M | -$1M | -$3M | |
Cash From Financing | $398.5M | $2M | -- | $2M | $82M | |
Beginning Cash (CF) | $399.8M | $1.6B | $277M | $518M | $227M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $538.6M | -$1.1B | -$82M | -$47M | -$41M | |
Ending Cash (CF) | $938.4M | $521M | $195M | $471M | $186M | |
Levered Free Cash Flow | -$154.4M | -$141M | -$138M | -$158M | -$150M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$643.4M | -$1.8B | -$765M | -$791M | |
Depreciation & Amoritzation | -- | $16M | $21M | $21M | $22M | |
Stock-Based Compensation | $36.9M | $212.1M | $166M | $157M | $142M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$549M | -$508M | -$612M | -$603M | |
Capital Expenditures | -- | $39.9M | -- | -- | -- | |
Cash Acquisitions | $294.4M | -$439K | -- | -- | -- | |
Cash From Investing | -- | -$1B | $173M | $55M | -$254M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$3M | -$9M | -$7M | |
Cash From Financing | -- | $1.1B | $9M | $833M | $572M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$417.6M | -$326M | $276M | -$285M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$598.6M | -$520M | -$633M | -$637M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$188.6M | -$77M | -$196M | -$165M | -$208M | |
Depreciation & Amoritzation | $6M | $6M | $5M | $5M | $6M | |
Stock-Based Compensation | $36.9M | $29M | $39M | $36M | $34M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$151M | -$136M | -$136M | -$150M | -$142M | |
Capital Expenditures | -- | $5M | -- | -- | -- | |
Cash Acquisitions | $294.4M | -- | -- | -- | -- | |
Cash From Investing | $291.1M | -$971M | $54M | $101M | $19M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1M | -$1M | -$3M | |
Cash From Financing | $398.5M | $2M | -- | $2M | $82M | |
Beginning Cash (CF) | $399.8M | $1.6B | $277M | $518M | $227M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $538.6M | -$1.1B | -$82M | -$47M | -$41M | |
Ending Cash (CF) | $938.4M | $521M | $195M | $471M | $186M | |
Levered Free Cash Flow | -$154.4M | -$141M | -$138M | -$158M | -$150M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.